Regenerative Medicine

Aging, illness, or trauma often lead to the deterioration of organs or tissues. Advancements in regenerative medicine have ushered in a new era of synthetic bone graft substitutes, which can be used when bones have been compromised by surgery or trauma. These substitutes not only provide a framework for bone growth but also stimulate protein aggregation and growth factor accumulation, which in turn induce osteoblast proliferation and differentiation¹ and promote bone regeneration. Given the popularity of autograft platelet-rich plasma (PRP) therapy, multiple growth factors have been used for tissue regeneration in the field of regenerative medicine.²

1. J Bone Joint Surg Am. 2011 Dec 7;93(23):2219-26. 2. Wound Care 2020 Jan 2;29(1):36-41.

Baxter Actifuse Shape Bone Graft Substitute

Baxter Actifuse Shape Bone Graft Substitute

Volume：1.6ml｜2.6ml｜7.5ml

ACTIFUSE Bone Graft substitute is a bone void filler intended only for orthopedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. ACTIFUSE Bone Graft substitute is indicated to be packed gently into bony voids or gaps of the skeletal system, i.e. extremities, pelvis and spine including use in posterolateral spinal fusion procedures with appropriate stabilizing hardware. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by bone during the healing process.

▲For registration license enquiries, please visit the website of the Food and Drug Administration of the Ministry of Health and Welfare:
https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=5497A1E8-B698-4ABD-9121-98D74594C90D

Baxter Actifuse Shape Bone Graft Substitute

Estar Tropocells PRP

Estar Tropocells PRP

The TropoCells Autologous Platelet Preparation Kit is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to an orthopedic surgical site.

▲For registration license enquiries, please visit the website of the Food and Drug Administration of the Ministry of Health and Welfare:
https://lmspiq.fda.gov.tw/web/MDPIQ/MDPIQ1000Result?licBaseId=AD375211-5CFA-45C3-B625-DDA5BD127AB3